FTAI is up +138.36% since Oct ’23 pick Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days £0.700 £0.85 Thursday, 30th May 2024 EVG.L stock ended at £0.750. During the day the stock fluctuated 0% from a day low at £0.750 to a day high of £0.750.
90 days £0.700 £1.10
52 weeks £0.700 £4.00

Historical Evgen Pharma plc prices

Date Open High Low Close Volume
Jan 05, 2024 £1.56 £2.00 £1.47 £1.73 13 817 148
Jan 04, 2024 £1.53 £1.56 £1.50 £1.50 477 062
Jan 03, 2024 £1.50 £1.60 £1.50 £1.60 113
Jan 02, 2024 £1.51 £1.63 £1.51 £1.60 10 102
Dec 29, 2023 £1.50 £1.62 £1.50 £1.60 670 018
Dec 28, 2023 £1.60 £1.60 £1.60 £1.60 0
Dec 27, 2023 £1.65 £1.69 £1.60 £1.60 3 954 598
Dec 22, 2023 £1.67 £1.67 £1.50 £1.60 31 772
Dec 21, 2023 £1.60 £1.60 £1.60 £1.60 0
Dec 20, 2023 £1.52 £1.70 £1.52 £1.60 45 121
Dec 19, 2023 £1.53 £1.70 £1.51 £1.60 2 000 000
Dec 18, 2023 £1.53 £1.67 £1.53 £1.60 96 735
Dec 15, 2023 £1.51 £1.70 £1.51 £1.60 1 743 418
Dec 14, 2023 £1.78 £1.78 £1.51 £1.60 1 549 072
Dec 13, 2023 £1.76 £1.76 £1.76 £1.76 453 514
Dec 12, 2023 £1.70 £1.80 £1.70 £1.76 1 327 709
Dec 11, 2023 £1.77 £1.77 £1.68 £1.70 36 549
Dec 08, 2023 £1.77 £1.77 £1.70 £1.70 6 650
Dec 07, 2023 £1.70 £1.70 £1.70 £1.70 650 000
Dec 06, 2023 £1.68 £1.78 £1.68 £1.70 51 404
Dec 05, 2023 £1.79 £1.79 £1.68 £1.70 62 195
Dec 04, 2023 £1.79 £1.79 £1.70 £1.70 900 000
Dec 01, 2023 £1.60 £1.80 £1.60 £1.70 1 018
Nov 30, 2023 £1.80 £1.80 £1.79 £1.79 201 395
Nov 29, 2023 £1.69 £1.79 £1.60 £1.60 651 628

FAQ

What are historical stock prices?
Historical stock prices refer to a stock’s recorded prices at various past points. These prices include several key figures that help investors and analysts evaluate a stock’s performance over time:
Open: Open price for the trading day.
High: Highest price for the trading day.
Low: Lowest price for the trading day.
Close: Close price for the trading day.

Additionally, historical prices often include:
Volume is the number of shares traded during the day. It indicates how actively a stock was traded and can provide insights into market sentiment and liquidity.

How can I use EVG.L stock historical prices to predict future price movements?
Trend Analysis: Examine the EVG.L stock’s historical trends to identify patterns that might continue.
Moving Averages: Use moving averages to detect potential reversal points.
Momentum Indicators: Apply indicators like RSI or MACD to assess the momentum and strength of price movements.
Volume Analysis: Analyze trading volume alongside price changes to gauge trend strength.
Statistical Methods: Use statistical tools such as regression analysis to model and forecast future prices based on past data.
These techniques can provide insights but should be used with risk management practices to mitigate potential losses.

What impact do stock splits have on historical price data?
When a company performs a stock split, it adjusts the historical price data to reflect the new, lower trading price as if it had always been that way.

This ensures consistency for anyone analyzing the stock’s past prices. The adjustment helps prevent misleading signals on charts, such as false sell signals or bearish trends that aren’t there. For instance, in a 2-for-1 stock split, the price per share is cut in half, which would otherwise appear as a dramatic drop on the chart. If someone didn’t know about the split, they might wrongly think something negative happened to the company. Most technical indicators would also react to this apparent drop by signaling to sell.

A stock split, while making the shares seem more affordable and potentially more attractive to investors, doesn’t alter the company’s fundamental value.

Why do the EVG.L stock historical prices show a range for periods like 30 days, 90 days, and 52 weeks?
The range provides the lowest and highest prices at which the stock has traded during the specified period. This helps investors understand the stock’s volatility and price variability within that timeframe.

How can I use historical price volatility to assess risk?
High price volatility historically indicates higher risk and potentially higher returns. Investors can gauge the stock’s risk level by examining the range between high and low prices over various periods.
Click to get the best stock tips daily for free!

About Evgen Pharma plc

Evgen Pharma plc Evgen Pharma plc, a clinical stage drug development company, focuses on the development of sulforaphane-based medicines for the treatment of cancer and inflammatory diseases. It develops its products using Sulforadex, a sulforaphane stabilization technology. The company's lead product is SFX-01, that is in Phase II clinical trials for the treatment of metastatic breast cancer; and in Phase Ib/IIa clinical trials for the treatment of glioblastoma,... EVG.L Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT